
Lumiface0.005%
Incepta Pharmaceuticals Ltd.
Trifarotene is a topical retinoid indicated for the treatment of acne vulgaris in patients 9 years of age and older.
Trifarotene is a topical retinoid indicated for the treatment of acne vulgaris in patients 9 years of age and older.
Use of Trifarotene for dermatologic conditions other than acne vulgaris has not been established and is not recommended.
| Population | Dose |
|---|---|
| Adults and adolescents ≥9 years | Apply a thin, uniform layer of Trifarotene cream once daily in the evening to the affected areas of the face and/or trunk. |
| Children under 9 years | Not recommended; safety and efficacy not established. |
Approximately one pump of Trifarotene cream is generally sufficient for the entire face; approximately two pumps are used for the upper trunk. Cleanse and dry the skin before application. A moisturizer may be applied and is generally recommended to help manage dryness or irritation, particularly at treatment initiation.
Clinical improvement with Trifarotene is usually assessed after about 12 weeks; consult a physician if no improvement is seen or if irritation is significant (see Precautions and Warnings).
The most commonly reported adverse reactions with Trifarotene are local skin reactions, generally most pronounced during the first 4 weeks of treatment and decreasing thereafter:
Severe or persistent irritation, blistering, or signs of an allergic reaction (rash, swelling, difficulty breathing) with Trifarotene should prompt discontinuation and medical evaluation.
Trifarotene is contraindicated in:
Disclaimer
The information provided is accurate to the best of our knowledge, but it does not replace professional medical advice. We cannot guarantee its completeness or accuracy, and the absence of specific information about a drug should not be taken as an endorsement. We are not responsible for any consequences arising from this information, so please consult a healthcare professional for any concerns or questions.